Migraine and dry eye disease share underlying inflammatory processes that may explain the association between the two conditions, a study found. Medscape Medical News
Author: Medscape
FDA Issues Class I Recall of Raindrop Near Vision Inlay Device
The recall stems from a postapproval study showing an increased risk for corneal haze associated with the device. News Alerts
FDA Approves Lotemax SM For Ocular Surgery Pain, Inflammation
The FDA has approved a new formulation of loteprednol etabonate ophthalmic gel (Lotemax SM, Bausch + Lomb) 0.38% for postoperative inflammation and pain following ocular surgery. FDA Approvals
Two-Stent Injection Lowers IOP in Various Glaucoma Types
Dr Shuchi Patel on the latest results with the trabecular microbypass iStent inject. Medscape Ophthalmology
Crosslinking: Is Using an Epi-On Technique Effective?
Dr Sumit (Sam) Garg on a new study that lends support to the much-debated procedure. Medscape Ophthalmology
Man Who Led Team to Approve LASIK Now Says It Was a Mistake
Years after he left the FDA and met people hurt by the procedure, Morris Waxler says he now sees the risks as too high and wants the FDA to add warnings. The FDA and an industry group respond. Medscape Medical News
Diabetes Eye Exam Frequency in US Is ‘Alarmingly Low’
In a large database of insured patients, almost half with type 2 diabetes and a third with type 1 diabetes had no eye exam in a 5-year period. Change is needed to stop retinopathy being the leading cause of blindness. Medscape Medical News
Diabetic Retinopathy: 2-Year Screening Interval May Be Okay
Findings suggest screening intervals could be lengthened, but both the study authors and editorialists urge caution pending further study. Medscape Medical News
Eye Movements May Flag Cognitive Impairment in Schizophrenia
A Japanese study found a significant association between visual exploration and scores on a cognitive test requiring visual search in patients with schizophrenia. Medscape Medical News
EU Panel Recommends Humira Biosimilars Idacio, Kromeya
The EMA’s Committee for Medicinal Products for Human Use has recommended marketing authorization for two biosimilars that are highly similar to Humira (adalimumab, AbbVie). International Approvals
Diabetes, Complications Reduce Odds of Successful DSEK
Dr Christopher Rapuano on the latest data from the Cornea Preservation Time Study. Medscape Ophthalmology
Anti-VEGF Efficacy in DME: Early Response Is Not Destiny
New data from Protocol T shows that eyes with poor 12-week response often had good vision at 2 years without switching therapies. Medscape Ophthalmology
Four Ocular Abnormalities Not to Overlook in Children
Even subtle symptoms may herald serious conditions. If missed on eye exams, they can have life-threatening consequences. Medscape Ophthalmology
Burnout Rises Above 50% in Some Specialties, New Survey Shows
Urologists had the highest burnout rates; 20% of all physicians said they have had thoughts of suicide or prefer not to answer. Medscape Medical News
Can Medical Marijuana Help Your Practice Thrive?
With more acceptance by states and interest by patients, the use of medical cannabis is growing. But there is a lot physicians need to know before considering a recommendation for treatment. Medscape Business of Medicine
Take Diabetes Into Consideration When Assessing for Glaucoma
Diabetes and hyperglycemia are associated with thicker central corneal thickness, a relationship that could lead to overestimation of intraocular pressure, researchers warn ophthalmologists. Medscape Medical News
FDA Clears Novel Eye Tracking Test to Detect Concussion
EyeBOX is the first noninvasive, baseline-free test to help in the diagnosis of concussion. The 4-minute test is appropriate for ages 5 to 67 years. FDA Approvals
Errors in Diagnosing Optic Neuritis–How Can We Fix Them?
A new study sheds light on the alarmingly high rate of misdiagnosis–and misallocated treatments–in this acute condition. Medscape Optometry
Diplopia and Upper Eyelid Ptosis in a 74-Year-Old Man
A 74-year-old man presents with variable diplopia and ptosis of the left upper eyelid. What is the most likely diagnosis? Medscape Ophthalmology
Netarsudil Lowers IOP, but When Should It Be Given?
Findings from the ROCKET trials shed light on –and also raise questions about –this newly approved medication for glaucoma. Medscape Ophthalmology